|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Nasal Polyps | |||||
| 2 | More general conditions related to this trial | ||||
| Nose Diseases | |||||
| Otorhinolaryngologic Diseases | |||||
| Pathological Conditions, Anatomical | |||||
| Polyps | |||||
| 3 | Interventions listed in this trial | ||||
| Prednisone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Samuel Lunenfeld Research Institute, Mount Sinai Hospital | |||||